Rare earth metal production was on the rise again in 2023, jumping to 350,000 metric …
Author
admin
-
-
-
-
-
Investing
Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302
by adminQuantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today …
-
-
-
-
-
